February News

February 28, 2023

Awards, New Papers and Announcements

Tetlow AM, Jackman BM, Alhadidy MM, Muskus P, Morgan DG, Gordon MN. Neural atrophy produced by AAV tau injections into hippocampus and anterior cortex of middle-aged mice. Neurobiol Aging. 2022 Dec 21;124:39-50. doi: 10.1016/j.neurobiolaging.2022.06.014. Epub ahead of print. PMID: 36739619.
Ehrenberg AJ, Kelberman MA, Liu KY, Dahl MJ, Weinshenker D, Falgàs N, Dutt S, Mather M, Ludwig M, Betts MJ, Winer JR, Teipel S, Weigand AJ, Eschenko O, Hämmerer D, Leiman M, Counts SE, Levey AI, Lancini E, Son G, Schneider C, Egroo MV, Liguori C, Wang Q, Vazey EM, Rodriguez-Porcel F, Haag L, Bondi MW, Vanneste S, Freeze WM, Yi YJ, Maldinov M, Gatchel J, Satpati A, Babiloni C, Kremen WS, Howard R, Jacobs HIL, Grinberg LT. (2023) Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART. Alzheimers Dement. doi: 10.1002/alz.12937. PMID: 36642985
"The Role of Striatal Cav1.3 Calcium Channels in Therapeutics for Parkinson's Disease" Caulfield ME, Manfredsson FP, Steece-Collier K. Handbook Exp Pharmacol. 2023 Jan 3. doi: 10.1007/164_2022_629. PMID: 36592226
Dr. Kathy Steece-Collier was interviewed for an article to appear in the CHM February “Med News” about the research goals related to the CavGene Therapeutics, Inc. company endeavors.